UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 861177 NEW YORK, NY

Back to AVIR Full portfolio

Position in AVIR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$10,783

-$1,693 QoQ

Shares Held

2,319

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#101

of 124 holders

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. AVIR ranks #169 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,086,683	$1,533,248,041
2	REGN	Regeneron Pharmaceuticals, Inc.	716,560	$446,803,817
3	ALNY	Alnylam Pharmaceuticals, Inc.	727,848	$219,104,078
4	INCY	Incyte Corp	1,508,720	$171,028,494
5	RVMD	Revolution Medicines, Inc.	912,335	$170,862,094
6	INSM	INSMED Inc	1,335,071	$142,345,265
7	IONS	Ionis Pharmaceuticals Inc	1,454,672	$115,340,938
8	MRNA	Moderna, Inc.	1,521,849	$106,575,080

All Filings in AVIR

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,783	2,319	0.0%	Shares	Defined	2026-08-13
2026-03-31	$12,476	2,319	-97.4%	Shares	Defined	2026-05-13
2023-06-30	$336,852	90,068	0.0%	Shares	Defined	2023-08-11
2023-03-31	$301,725	90,068	0.0%	Shares	Defined	2023-05-15
2022-12-31	$433,225	90,068	+3.0%	Shares	Defined	2023-02-14
2022-09-30	$497,578	87,448	-13.9%	Shares	Defined	2022-11-14
2022-06-30	$721,260	101,586	+529.1%	Shares	Defined	2022-08-12
2022-03-31	$116,595	16,149	0.0%	Shares	Defined	2022-05-16
2021-12-31	$144,372	16,149	+27.9%	Shares	Defined	2022-02-14
2021-09-30	$442,667	12,626	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.